These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10413337)

  • 1. Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. Europen Medicine and Pregnancy Group.
    De Jong van den Berg LT; Feenstra N; Sorensen HT; Cornel MC
    Teratology; 1999 Jul; 60(1):33-6. PubMed ID: 10413337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.
    Meijer WM; Cornel MC; Dolk H; de Walle HE; Armstrong NC; de Jong-van den Berg LT;
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):675-82. PubMed ID: 16761260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children.
    Schirm E; Tobi H; de Jong-van den Berg LT
    J Clin Epidemiol; 2004 Jul; 57(7):737-41. PubMed ID: 15358402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Swedish National Pharmacy Register.
    Astrand B; Hovstadius B; Antonov K; Petersson G
    Stud Health Technol Inform; 2007; 129(Pt 1):345-9. PubMed ID: 17911736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional information from parental questionnaires and pharmacy records for registration of birth defects. EuroMAP-group.
    Reefhuis J; de Walle HE; de Jong-van den Berg LT; Cornel MC
    Eur J Epidemiol; 2000 Apr; 16(4):329-36. PubMed ID: 10959940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Registration of drug use in a birth defect monitoring system: a priority worthy of emphasis!
    de Vries CS; de Walle HE; Cornel MC; de Jong-van den Berg LT
    Int J Risk Saf Med; 1993; 4(1):27-33. PubMed ID: 23511175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are patients reliable when self-reporting medication use? Validation of structured drug interviews and home visits by drug analysis and prescription data in acutely hospitalized patients.
    Glintborg B; Hillestrøm PR; Olsen LH; Dalhoff KP; Poulsen HE
    J Clin Pharmacol; 2007 Nov; 47(11):1440-9. PubMed ID: 17962430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of antirheumatic drugs in mothers and fathers before and during pregnancy-a population-based cohort study.
    Viktil KK; Engeland A; Furu K
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):737-42. PubMed ID: 19504626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the representativeness of a Dutch non-malformed control group for the general pregnant population: are these controls useful for EUROCAT?
    Jentink J; Zetstra-van der Woude AP; Bos J; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1217-23. PubMed ID: 21954020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool.
    Monster TB; Janssen WM; de Jong PE; de Jong-van den Berg LT;
    Pharmacoepidemiol Drug Saf; 2002; 11(5):379-84. PubMed ID: 12271879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancies between medication records of anticoagulation clinics and pharmacy records.
    Schalekamp T; Smit C; van Geest-Daalderop JH; de Vries-Goldschmeding H; de Boer A
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):823-8. PubMed ID: 16835939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics that predict locating and interviewing mothers identified by a state birth defects registry and vital records.
    Gilboa SM; Mendola P; Olshan AF; Savitz DA; Herring AH; Loomis D; Langlois PH; Keating K
    Birth Defects Res A Clin Mol Teratol; 2006 Jan; 76(1):60-5. PubMed ID: 16397888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany.
    Berger K; Eickhoff C; Schulz M
    J Clin Pharm Ther; 2005 Feb; 30(1):45-57. PubMed ID: 15659003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low agreement was found between pharmacy data and physician reported use of hospital-administered antenatal corticosteroids.
    Cederholm M; Alexandersson B; Kieler H
    J Clin Epidemiol; 2007 May; 60(5):512-7. PubMed ID: 17419962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of specific antimigraine drug use--a study based on the records of 18 community pharmacies.
    Lohman JJ; van der Kuy-de Ree MM;
    Cephalalgia; 2005 Mar; 25(3):214-8. PubMed ID: 15689197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands.
    Bakker MK; Jentink J; Vroom F; Van Den Berg PB; De Walle HE; De Jong-Van Den Berg LT
    BJOG; 2006 May; 113(5):559-68. PubMed ID: 16637899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacovigilance of over-the-counter products based in community pharmacy: methodological issues from pilot work conducted in Hampshire and Grampian, UK.
    Layton D; Sinclair HK; Bond CM; Hannaford PC; Shakir SA
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):503-13. PubMed ID: 12426936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal periconceptional illicit drug use and the risk of congenital malformations.
    van Gelder MM; Reefhuis J; Caton AR; Werler MM; Druschel CM; Roeleveld N;
    Epidemiology; 2009 Jan; 20(1):60-6. PubMed ID: 19057385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misclassification of exposure is high when interview data on drug use are used as a proxy measure of chronic drug use during follow-up.
    Beiderbeck AB; Sturkenboom MC; Coebergh JW; Leufkens HG; Stricker BH
    J Clin Epidemiol; 2004 Sep; 57(9):973-7. PubMed ID: 15504640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring medication: do interviews agree with medical record and pharmacy data?
    Korthuis PT; Asch S; Mancewicz M; Shapiro MF; Mathews WC; Cunningham WE; McCutchan JA; Gifford A; Lee ML; Bozzette SA
    Med Care; 2002 Dec; 40(12):1270-82. PubMed ID: 12458308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.